Hantavirus Symptoms Day by Day: What to Watch For After Possible Exposure
Hantavirus has a misleadingly gentle beginning. The first phase looks exactly like influenza. The transition to severe disease happens fast, sometimes within hours, and the difference between survival and death often comes down to whether someone recognized what was happening early enough to get to a hospital with respiratory support. This is the timeline that matters.
The full timeline at a glance
From the moment of exposure to either recovery or death, hantavirus follows a fairly consistent timeline across the pulmonary syndrome (HPS) strains that dominate the Americas. Hemorrhagic fever with renal syndrome (HFRS) caused by Eurasian strains has a different organ focus but similar early phases. The framework below applies primarily to HPS, with HFRS notes where relevant.
Phase 1: Incubation (Days 0 to 28-56)
Symptoms: None.
The incubation period after exposure ranges from 1 to 8 weeks depending on the strain. Most cases develop symptoms in the 2-4 week range. During this entire period, the infected person feels normal and has no idea anything is wrong. They are not contagious to others (with the rare Andes virus exception, which has its own dynamics).
Importantly, the incubation period is silent only externally. Internally, the virus is replicating in vascular endothelial cells, particularly in the lungs (for HPS) or kidneys (for HFRS). The body's immune response is gearing up. By the end of incubation, the immune system is primed for an aggressive response that will both fight the virus and cause much of the disease's worst symptoms.
Phase 2: Prodromal / Febrile (Days 1 to 4 of symptoms)
Symptoms: Fever, fatigue, severe muscle aches (especially thighs, hips, lower back), headache, sometimes nausea/vomiting/diarrhea.
This is the phase most often misdiagnosed as flu, food poisoning, or generic viral infection. Symptoms come on relatively suddenly. The fever is typically high (38.5-40°C / 101-104°F). Muscle pain is described by patients as deep, severe, and distinctly different from ordinary flu aches.
About half of patients also experience gastrointestinal symptoms during this phase. Vomiting and diarrhea are common, which can lead to dehydration and electrolyte disturbances that complicate later treatment. Some patients are admitted to hospitals at this stage for fluid management without anyone considering hantavirus.
Critical detail: cough and shortness of breath are typically NOT present during phase 2. This is what fools clinicians. A patient presenting with high fever, severe muscle aches, and gastrointestinal upset, but with clear lungs, does not trigger pulmonary alarm bells. Yet this is precisely the patient who will deteriorate dramatically in 24-72 hours.
Diagnostic note: even hantavirus-specific testing is unreliable during phase 2. The virus has not yet reached detectable levels in routine PCR samples. IgM antibodies are only beginning to develop. Repeat testing 72 hours later is often required for laboratory confirmation. This is why clinical suspicion based on exposure history matters so much during this phase.
Phase 3: Critical transition (Days 4 to 7 of symptoms)
Symptoms: Onset of cough, shortness of breath, chest tightness, rapid heart rate. Continued fever.
This is the danger zone. Over a period of hours to two days, the patient transitions from a flu-like illness to a critical respiratory emergency. Fluid begins accumulating in the lungs. Oxygen saturation drops. The patient feels like they cannot get enough air, then they cannot.
The transition can be remarkably fast. Case reports describe patients sent home from emergency departments with a diagnosis of viral illness, who returned 12-24 hours later in respiratory failure. Others have collapsed at home, on airplanes, or in transit. The 2026 MV Hondius cluster included a case where a passenger boarded a flight feeling unwell and deteriorated severely during the flight, dying shortly after landing.
Specific warning signs during this window:
- New onset shortness of breath, especially with mild exertion
- Rapid breathing (more than 24 breaths per minute at rest)
- Feeling of chest tightness or difficulty taking deep breaths
- Cough, particularly if non-productive
- Rapid heart rate (over 100 bpm at rest)
- Persistent or worsening fever after 4-5 days
Any of these in a patient with prior rodent exposure or known hantavirus contact is a medical emergency. The relevant action is direct travel to an emergency department, not waiting for an outpatient appointment.
Phase 4: Cardiopulmonary / Severe (Days 5 to 12 of symptoms)
Symptoms: Severe respiratory distress, low blood pressure, possible shock, pulmonary edema, sometimes cardiogenic shock.
By this point, patients are typically in intensive care. The lungs fill with fluid (pulmonary edema) that is non-cardiogenic in origin, meaning it is not caused by heart failure but by leaky blood vessels in the lungs from the viral effect. Standard ventilator strategies for ordinary pneumonia often work poorly. Many patients require ECMO (extracorporeal membrane oxygenation) to maintain oxygenation.
Cardiac involvement is also common. The heart's pumping ability may decrease, contributing to low blood pressure that does not respond well to fluid resuscitation. In fact, aggressive fluid replacement can worsen the pulmonary edema. Treatment requires a careful balance between adequate perfusion and minimizing lung fluid load.
This is also when most deaths occur. Mortality is decided in this phase by the quality of supportive care available. With ECMO and intensive care, mortality drops from the historical 38-50 percent to around 20 percent. Without ECMO, outcomes depend on how quickly stable oxygenation can be maintained through conventional ventilation.
For HFRS strains, the analogous phase involves kidney failure rather than pulmonary failure. Patients may produce very little urine, develop hypertension, and may require dialysis. Hemorrhagic complications can occur but are less common with European strains than with Hantaan.
Phase 5: Diuretic / Recovery (Days 7 to 21 of symptoms)
Symptoms: If the patient survives phase 4, large urine output begins. Breathing improves. Strength gradually returns.
The pulmonary edema resolves over several days as the vascular leakage stops. Patients may produce enormous amounts of urine (sometimes 4-6 liters per day) as accumulated fluid is excreted. Oxygen requirements decrease. Most patients can be extubated within 5-10 days of intensive care admission.
Full recovery, however, is slow. Lung function may take weeks to months to return to baseline. Some patients experience persistent shortness of breath on exertion for 6-12 months. Cognitive symptoms (fatigue, brain fog, concentration difficulty) are common and can last similar periods.
HFRS recovery follows a similar pattern but with kidney function as the limiting factor. Most patients regain normal kidney function within weeks to months. Long-term hypertension is reported in some series.
Phase 6: Late recovery (Months 1 to 12)
Symptoms: Gradually improving fatigue, exercise intolerance, possible mild persistent symptoms.
Survivors of severe hantavirus typically describe a long recovery. Many return to baseline within 3-6 months. Some report ongoing fatigue or reduced exercise tolerance for a year or more. There is no documented chronic infection or recurrence; the virus is fully cleared. The lingering symptoms reflect the severity of the acute illness rather than ongoing viral activity.
The critical decision points
For someone with possible exposure who is monitoring themselves or a family member, three decision points matter most.
First decision point: Day 1-2 of symptoms. If you have flu-like symptoms AND you had rodent exposure in the past 1-8 weeks, OR you had close contact with someone with confirmed hantavirus, OR you traveled in Argentina/Chile/Uruguay/other Andes virus regions in that window: contact a doctor and explicitly mention the exposure history. Ask about hantavirus testing. Even if testing is negative, this puts hantavirus on the radar for the days ahead.
Second decision point: Day 4-5 of symptoms. If fever persists, muscle aches are severe, and you have ANY new respiratory symptoms (cough, shortness of breath, chest tightness), go to an emergency department immediately. Do not wait. Do not try to schedule outpatient evaluation. The transition to phase 3 can happen within hours and the difference matters.
Third decision point: Any rapid breathing. A respiratory rate over 24 per minute at rest, in someone with known hantavirus exposure history or recent flu-like illness, is an emergency regardless of other signs. Call emergency services. Do not drive yourself if it can be avoided.
What makes the timeline unusual
Compared to other severe respiratory infections, hantavirus has two distinguishing features that this timeline reveals:
The first is the speed of the transition from phase 2 (flu-like) to phase 4 (cardiopulmonary failure). For most respiratory viruses, severe illness develops gradually over a week. For hantavirus, the transition is often a 24-hour event. This is why the recommendation to seek emergency care at the first respiratory symptoms is so aggressive.
The second is that survival depends almost entirely on supportive care quality. There is no antiviral cure for hantavirus. Ribavirin has shown some effect for HFRS in Asian trials but does not help HPS. The treatment is keeping the patient alive through the cardiopulmonary phase until the immune system clears the virus and the vascular leakage stops. ECMO availability is the single biggest determinant of survival in severe cases.
These two factors together explain why hantavirus mortality remains high even in developed health systems. The window for intervention is narrow, the diagnostic clues are subtle in early phases, and even with optimal care, roughly one in five hospitalized patients does not survive.
For people in endemic regions or with possible exposure: knowing this timeline is the most useful protection available. Antibiotics will not help. Standard antivirals will not help. Recognition and rapid escalation of care are what change outcomes.